Cipla To Hold Off On Pediatric Cancer Drug Generic Until 2033
Specialty drugmaker Fennec Pharmaceuticals has jointly announced with Indian multinational pharmaceutical company Cipla Ltd. that they had reached an agreement to settle patent infringement litigation in exchange for Cipla delaying the...To view the full article, register now.
Already a subscriber? Click here to view full article